Author

Shriyansh Srivastava

Institution: Galgotias University

Observed institutions: Galgotias University, Indian Institute of Technology Gandhinagar, National Institute of Pharmaceutical Education and Research

ORCID: 0000-0001-9100-6528

Observed ORCID: 0000-0001-9100-6528

OpenAlex ID: A5102998189

Inhibition of MK2 kinase as a potential therapeutic target to control neuroinflammation in Alzheimer’s disease

2021 · Shriyansh Srivastava, Rohan Rajopadhye, et al. · Expert Opinion on Therapeutic Targets · 11

REV ‐ ERBβ Binding Pocket Dynamics With Implications for Rational Design of Small Molecule Modulators

2025 · Shriyansh Srivastava, Vishnu A. M., et al. · Proteins Structure Function and Bioinformatics · 2

Works count: 4

Citation count: 13

H-index: 2

I10-index: 1